Biologic Activity of Virus Isolated From PBMC and Plasma of LTS and Progressors
| Subject . | Source of Virus . | Phenotype of Primary Virus/Total Tested* . | |
|---|---|---|---|
| NSI . | SI . | ||
| LTS | PBMC | 9/10 (90%) | 1/10 (10%) |
| Progressors | PBMC | 7/16 (44%) | 9/16 (56%) |
| LTS | Plasma | Not tested4-151 | Not tested4-151 |
| Progressors | Plasma | 0/8 | 8/8 |
| Subject . | Source of Virus . | Phenotype of Primary Virus/Total Tested* . | |
|---|---|---|---|
| NSI . | SI . | ||
| LTS | PBMC | 9/10 (90%) | 1/10 (10%) |
| Progressors | PBMC | 7/16 (44%) | 9/16 (56%) |
| LTS | Plasma | Not tested4-151 | Not tested4-151 |
| Progressors | Plasma | 0/8 | 8/8 |
*Assayed with MT-2 cells as described in Materials and Methods.
Infectious virus could not be isolated from the plasma of the 12 individuals tested.